Shares of JOY Co., Ltd. (TSE:JOY – Get Free Report) passed below its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of C$5.01 and traded as low as C$4.91. JOY shares last traded at C$4.96, with a volume of 734,797 shares traded.
JOY Trading Down 11.4%
The company’s fifty day moving average is C$5.61 and its two-hundred day moving average is C$5.01. The stock has a market cap of C$334.71 million, a price-to-earnings ratio of 13.05, a PEG ratio of 0.01 and a beta of 0.98. The company has a quick ratio of 0.95, a current ratio of 0.58 and a debt-to-equity ratio of 12.34.
JOY (TSE:JOY – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported C$0.26 earnings per share (EPS) for the quarter. JOY had a net margin of 15.09% and a return on equity of 7.55%. The company had revenue of C$55.38 million during the quarter. On average, research analysts predict that JOY Co., Ltd. will post 0.26 EPS for the current fiscal year.
Insider Buying and Selling at JOY
In other news, insider Gerald Gilewicz acquired 30,000 shares of JOY stock in a transaction dated Tuesday, October 13th. The shares were acquired at an average cost of C$5.64 per share, for a total transaction of C$169,200.00. Following the acquisition, the insider owned 444,875 shares of the company’s stock, valued at C$2,509,095. This trade represents a 7.23% increase in their ownership of the stock. Insiders own 7.64% of the company’s stock.
JOY Company Profile
Journey is a Canadian exploration and production company focused on oil-weighted operations in Alberta, Canada. Journey’s strategy is to grow its production base by drilling on its existing core lands, implementing secondary and tertiary flood projects on its existing lands, and by executing on accretive acquisitions. The Company continues to shift its focus to the development of its unconventional Duvernay light oil resource play. In addition, Journey is continuing with its plans to grow its power generation business through its projects at Gilby and Mazeppa.
Featured Stories
- Five stocks we like better than JOY
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for JOY Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JOY and related companies with MarketBeat.com's FREE daily email newsletter.
